| dc.contributor.author | Aksu, Salih | |
| dc.contributor.author | Sahin, Fahri | |
| dc.contributor.author | Uz, Burak | |
| dc.contributor.author | Yavuz, Selim A. | |
| dc.contributor.author | Atay, Hilmi | |
| dc.contributor.author | Kelkitli, Engin | |
| dc.contributor.author | Turgut, Mehmet | |
| dc.contributor.author | Pehlivan, Mustafa | |
| dc.contributor.author | Akay, Meltem O. | |
| dc.contributor.author | Guray, Emel | |
| dc.contributor.author | Demir, Muzaffer | |
| dc.contributor.author | Kahraman, Selda | |
| dc.contributor.author | Demirkan, Fatih | |
| dc.contributor.author | Paydas, Semra | |
| dc.contributor.author | Saydam, Giiray | |
| dc.contributor.author | Haznedaroglu, Ibrahim C. | |
| dc.date.accessioned | 2019-12-10T11:20:43Z | |
| dc.date.available | 2019-12-10T11:20:43Z | |
| dc.date.issued | 2012 | |
| dc.identifier.issn | 1306-133X | |
| dc.identifier.uri | https://doi.org/10.4999/uhod.12004 | |
| dc.identifier.uri | http://hdl.handle.net/11655/15374 | |
| dc.description.abstract | We report our experience in 41 patients with chronic phase (CF)-chronic myeloid leukemia (CML) who had discontinued imatinib switched to dasatinib, retrospectively. The CF-CML patients received dasatinib at starting dose of 100 once daily. Dose adjustment were observed in 11 patients, respectively. In case of other circumstances, treatment has been continued with a lower dose if needed. The median dose of dasatinib was 100 mg daily (range: 50 to 140 mg). We conclude that even low-dose dasatinib therapy is an effective and safe in second line treatment of CML patients patients. | |
| dc.language.iso | en | |
| dc.publisher | Akad Doktorlar Yayınevi | |
| dc.relation.isversionof | 10.4999/uhod.12004 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Oncology | |
| dc.title | The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.relation.journal | Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi | |
| dc.contributor.department | İç Hastalıkları | |
| dc.identifier.volume | 22 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 8 | |
| dc.identifier.endpage | 14 | |
| dc.description.index | WoS | |
